Furthermore, PARP inhibition may prevent plaque development by decreasing inflammatory factors and interfering with plaque dynamics-related cellular changes, thus being a promising strategy for the treatment of atherosclerosis [101]. This evidence concerns the gene PARP1 and atherosclerosis.